Västra Hamnen: Analysuppdatering Q2 2022

BioStock: Chordate sums up H1 and projects sales growth

BioStock: Chordate’s CSO is looking forward to the migraine results

Analys Group: Planen för 2022 fortsatt intakt

BioStock: Chordate Medical opens representative office in Saudi Arabia

BioStock: Chordate Medical’s CEO on the marketing and sales plans

Analyst Group: Chordate Medical Q4-21

Analyst Group: Kommentar på Chordate Medicals Q4-rapport

BioStock: Chordate Medical’s CEO on UK market introduction

BioStock: Chordate enters 2022 with strong confidence